Chagas Heart Failure Treatment Advance | Brazil Study
Dive into the PARACHUTE-HF trial's breakthrough: sacubitril/valsartan shows superior biomarker reduction in Chagas heart failure. Led by Brazilian universities like Unesp, this JAMA-published study advances treatment for millions affected.
research-publication-newsheart-failure-treatmentbrazilian-universities
